Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
ONCY
Primary Symbol:
T.ONC
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and...
adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(185)
•••
CMHarring218431
X
View Profile
View Bullboard History
Comment by
CMHarring218431
on Nov 11, 2024 11:53am
RE:RE:RE:RE:Notice of Conference Call the Day Before
Please let it be a large buyout offer. Volume toward the end of the day might indicate that it is more than a change in corporate management In the meantime, if you know a veteran take time
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 11, 2024 11:51am
RE:RE:RE:RE:RE:“Second mouse gets the cheese “
The irony of CGON's pursuit of bladder cancer is that in around 2007 Brad Thompson had the opportunity of addressing the bladder cancer market with pelareorep but chose not to do so. This speaks
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 11, 2024 11:46am
RE:RE:RE:RE:“Second mouse gets the cheese “
A single late stage clinical study in non-invasive/muscle invasive bladder cancer using an intravesically administered OV in combination with an immune checkpoint inhibitor (nivolumab) has CG
...more
(479)
•••
Peladawn
X
View Profile
View Bullboard History
Comment by
Peladawn
on Nov 11, 2024 11:32am
RE:RE:RE:Notice of Conference Call the Day Before
Cm....I'm certainly no authority in corporate affairs, just a lowly sailor.....but I think you're right...quarterly results will be announced after close to give us time to digest the
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 11, 2024 11:29am
RE:RE:RE:RE:“Second mouse gets the cheese “
https://www.biospace.com/press-releases/replimune-presents-late-breaking-abstract-featuring-data-from-ignyte-clinical-trial-of-rp1-combined-with-nivolumab-in-anti-pd1-failed-melanoma-at-the-39th
...more
(78)
•••
venture009
X
View Profile
View Bullboard History
Comment by
venture009
on Nov 11, 2024 11:26am
RE:RE:RE:Notice of Conference Call the Day Before
At the moment there is very little enthusiasm for this stock, so if they don't have something of substance to report the sp will suffer. Any suggestion of a reverse split will be a death nil for
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 11, 2024 11:16am
RE:RE:RE:“Second mouse gets the cheese “
https://www.biospace.com/press-releases/cg-oncology-announces-nature-medicine-publication-of-phase-1b-study-results-evaluating-cretostimogene-grenadenorepvec-in-combination-with-nivolumab-in-muscle
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 11, 2024 11:07am
RE:RE:RE:ONCY Presented Positive GOBLET Pancreatic Cancer Data @ ESMO
As a further follow-up on the information presented - it is necessary to understnd that an adaptive Phase 2 cliniclal trial for a drug that is then granted a FDA Accelerated Approval, as early
...more
(185)
•••
CMHarring218431
X
View Profile
View Bullboard History
Comment by
CMHarring218431
on Nov 11, 2024 10:38am
RE:RE:Notice of Conference Call the Day Before
Peladawn past two conference calls were at 4:30 after results gave investors time to digest. This Q .....conference call at 8:30. Does that mean results and a corporate update will be announced after
...more
(111)
•••
Aftereight
X
View Profile
View Bullboard History
Post by
Aftereight
on Nov 11, 2024 10:38am
i
I am hoping it is BIG news, like a buyout!! Wishful thinking! LOL
(479)
•••
Peladawn
X
View Profile
View Bullboard History
Comment by
Peladawn
on Nov 11, 2024 10:14am
RE:Notice of Conference Call the Day Before
It's obvious they were waiting for some pivitol event to take place before making the announcement. Guess we'll all find out tomorrow am.....maybe along with a trading halt?
(129)
•••
JohnnyYeg
X
View Profile
View Bullboard History
Post by
JohnnyYeg
on Nov 11, 2024 9:58am
Notice of Conference Call the Day Before
Is it normal or acceptable business practice to announce a corporate quarterly earnings call the day before said call? It's definitely not "courteous", but then what is with publicly
...more
(216)
•••
13X2413
X
View Profile
View Bullboard History
Comment by
13X2413
on Nov 11, 2024 9:48am
RE:RE:RE:RE:New Press Release - Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights
Yeah. Another fireside chat announcement.
(185)
•••
CMHarring218431
X
View Profile
View Bullboard History
Comment by
CMHarring218431
on Nov 11, 2024 9:28am
RE:RE:RE:New Press Release - Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights
Announcing 3rd Q results will be released the next day is a bit unusual. Sense of urgency? Does setting the conference call up an hour before market opens suggest anything?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden